$標普500指數 (.SPX.US)$rose 0.2% on Thursday, driven by strong earnings from Tesla and others. Meanwhile,$納斯達克綜合指數 (.IXIC.US)$gained 0.8%, and$道瓊斯指數 (.DJI.US)$fell 0.3%. $特斯拉 (TSLA.US)$stock soared 21.9% after posting better-than-expected Q3 profits and a higher gross margin. The company also reaffirmed its plan for an affordable EV model. $Molina Healthcare (MOH.US)$surged 17.7% due to strong premium r...
CLICK HERE: TYNKR LAB™ Both the U.S. and Bursa Malaysia markets experienced volatility amidst global economic uncertainty and investor caution ahead of the U.S. Federal Reserve’s expected interest rate cut. While the U.S. stock market saw declines, Bursa Malaysia ended lower as well, with losses driven by various sectoral pressures. U.S. Stock Market Performance Overview U.S. equities closed lower on Wednesday, with$道瓊斯指數 (.DJI.US)$falling b...
RECAP U.S. equity indexes rose after Thursday, with the$納斯達克綜合指數 (.IXIC.US)$lagging the pack, as investors weighed retail sales and jobless claims ahead of more inflation data this week. The$標普500指數 (.SPX.US)$rose 0.58% to 5,029, a new closing high with the$道瓊斯指數 (.DJI.US)$up 0.91% to 38,664. The$納斯達克綜合指數 (.IXIC.US)$was moderately higher at 15,906, af...
Analysts worry about the company's shifting tone and the enduring effect of clients' inventory management on West's finances. Doubts also arise about the company's demand visibility and if current trends suggest a fundamental issue in West's base business.
Jefferies analyst David Windley sees FDA approvals of GLP-1s for obesity treatment as a huge opportunity for the manufacturing supply chain. He also notes high rivalry in the injectable fill/finish market. Windley upgraded West Pharmaceutical to Buy, raising its price target by 66% to $536, citing its global footprint and capacity to meet growing GLP-1s demand.
The market sentiment around West Pharmaceutical Services hasn't changed much over the past five years, with the share price seemingly reacting to the EPS. The recent improvement in TSR could indicate that the business is getting better with time.
The 4- and 5-star rated Dividend Aristocrats for 2024 include Abbott Laboratories, AbbVie Inc., Air Products & Chemicals, and others such as Coca-Cola Co., McDonald's Corp., Walmart Inc., and West Pharmaceuticals.
West Pharmaceutical Services股票討論
$特斯拉 (TSLA.US)$ stock soared 21.9% after posting better-than-expected Q3 profits and a higher gross margin. The company also reaffirmed its plan for an affordable EV model.
$Molina Healthcare (MOH.US)$surged 17.7% due to strong premium r...
Both the U.S. and Bursa Malaysia markets experienced volatility amidst global economic uncertainty and investor caution ahead of the U.S. Federal Reserve’s expected interest rate cut. While the U.S. stock market saw declines, Bursa Malaysia ended lower as well, with losses driven by various sectoral pressures.
U.S. Stock Market
Performance Overview
U.S. equities closed lower on Wednesday, with $道瓊斯指數 (.DJI.US)$ falling b...
U.S. equity indexes rose after Thursday, with the $納斯達克綜合指數 (.IXIC.US)$ lagging the pack, as investors weighed retail sales and jobless claims ahead of more inflation data this week.
The $標普500指數 (.SPX.US)$ rose 0.58% to 5,029, a new closing high with the $道瓊斯指數 (.DJI.US)$ up 0.91% to 38,664. The $納斯達克綜合指數 (.IXIC.US)$ was moderately higher at 15,906, af...
暫無評論